chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a female who on 03-DEC-2007 was vaccinated with 0.65 ml ZOSTAVAX injection.  Concomitant therapy included olmesartan medoxomil (BENICAR).  Subsequently, the patient experienced lip burning and peeling.  Additional information is not expected.
woke up w/fever 13AUg93 8-9AM t102.6, irritable & slept more than usual, vomitted 4 seperate times, also vomitted APAP when tired to give, mom bathe pt w/luke warm H20;
Fever, cough, vomiting, anorexia started night after pt rec'd vaccines.
Fever (mild), chills. Headache, body aches. Fatigue. All lasting approximately 48 hours. Joint aches lasting 10 days.
Large area of the deltoid, red, warm to the touch, raised na and very swollen.
headache, lightheadedness, fatigue, joint pain, diarrhea, normal vaccine site tenderness, chills
11/01/11 Flu shot. 11/06/11 Sore throat, runny nose. 11/18/11 Burning in hands & feet. Unsteady walking. 11/21/11 Fell down, walking worsened. 11/23 Severe back pain & constipation went to Emergency on 11/24/11 at 6:00 AM. They did MRI, morphine, pres. & sent home. 11/26/11 Called rescue - admit to Hosp. 12/08/11 Released from Hosp.
pt had moderna  booster on 12/27/21 at pharmacy, pt came back on 01/28/2022 around 4.30 pm at the pharmacy saying she cant lift her left arm like normal any more, and having muscle cramp from neck to all the way to back on left side  and do go any further, and she said it has happened ever since she had moderna booster, no inflamation at the site of injection
Patient recvd influenza vaccine 10/12/16 came in office on 10/17/16 with c/o patient has fever, sore throat and vomited once. A strep culture was done results were negative.
I received the vaccine on January 8, 2021.  On the evening of January 15, the injection site started to itch.  The next morning when I woke up, the injection site was hard and feverish.  The swelling continued to spread until it covered the top of my deltoid muscle.  I contacted the health department but never heard back from them with advice.  I took Tylenol and used ice on it.  It was still swollen the next day.  I contacted a family member who is a nurse.  She advised that I try warm compresses instead.  Today (1/18/2021) I went to my personal physician.  The swelling is still present and feverish.  It measures 16 cm x 12cm.  There is redness visible.  I was given Augmentin and asked to continue with warm compresses.
1121 Patient started feeling hot, face red, throat feeling dry and tight.  Vital signs: Blood pressure 122/78 Heart rate 88 SATS 99% ON ROOM AIR. Patient was given Benadryl 25 mg by mouth. After about 15 minutes after administration, patient noted her "hot flash" had dissipated and her "funny feeling in throat" had minimized. She denied difficulty breathing or swallowing. Patient was discharged at 12:00. At 12:15, patient returned appearing slightly flushed and complaining of feeling warm again. While accompanying patient to Convenient Care, patient noted her throat "felt funny" and had to clear her throat to speak. Patient was transferred to convenient care nurse at 12:20
Patient reports swollen small bump in arm after flu shot and is still there. Painful when she touches it.
Complaint of "prickly" sensation after vaccine at site in L deltoid, down to full five fingers.  Noted a bit of sciatic; has historically, not upon arrival. No apparent rash, itching, no shortness of  breath; throat a bit dry. BP 142/80; pulse 62; p ox 98; fairly normal vitals for her. As sat and monitored, increased BP to 162/90. After 10-15 minutes, arm better; BP 148/76. Felt stable; wanting to leave as going to MD  with husband. After walking in hall, felt "sharp pain in coccyx", lost balance and leaned on wall. BP 150/90. At this point, decided to be evaluated by ED; rapid response and transported by wheelchair.
pt passed out 10 mins p/vax given mild sz activity noted drooling snorting sounds; Epi given; pt refused emergency care;
pt recvd vax & w/in 30mins p/vax pt exp spots a/eyes,dizziness,inc pulse,sl inc BP 130/64,hot flashes,chills,tingling & then resolved;they returned approx 30mins later & are now resolving w/rest
Chills; subjective fevers less than 100; fatigue; soreness at injection site; This is a spontaneous report from a contactable physician (the patient). A 28-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 16Dec2020 (at the age of 28-years-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 16Dec2020, the patient experienced chills, subjective fevers less than 100, fatigue, and soreness at injection site 24 hours. The clinical outcome of chills, subjective fevers less than 100, fatigue, was recovered on an unspecified date. The clinical outcome of soreness at injection site 24 hours was recovered on 17Dec2020. It was also reported that since the vaccination, the patient had not been tested for COVID-19.     Information on the lot/batch number has been requested.
This case was reported by a consumer via call center representative and described the occurrence of general body pain in a female patient who received SHINGRIX for prophylaxis. Concurrent medical conditions included spinal cord injury. On an unknown date, the patient received the 1st dose of SHINGRIX .5 ml. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced general body pain. On an unknown date, the outcome of the general body pain was recovered/resolved. It was unknown if the reporter considered the general body pain to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. Three months from the date of reporting the patient experienced body aches and pains that lasted for about a week and then resolved.
pt recvd vax; on 14oct95 exp n, v; 16oct95 was found to have elev LFTs; to ER;
This case was reported by a physician and described the occurrence of sore throat in a 33-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). On either 14 April 2010 or 19 April 2010 (conflicting information was provided), the subject received 1st dose of ENGERIX B (20 mcg, unknown route, left arm). On either 16 April 2010 or 21 April 2010, 48 hours after vaccination with ENGERIX B, the subject experienced sore throat, fever, shortness of breath and gastrointestinal symptoms. The subject visited an urgent care office and her heart rate was monitored (results not provided), but she was not treated and was not hospitalized. At the time of reporting the events were resolved. The physician considered the events of sore throat, shortness of breath and gastrointestinal symptoms were probably related to vaccination with ENGERIX B. Causality statement for the event of fever was not provided.
Information has been received from a nurse practitioner concerning a 33 year old female with pertinent medical history and drum reactions allergies reported as none who on 10/26/06 was inadvertently vaccinated with Pneumococcal 23v polysaccharide vaccine, 0.1 ml, one time, intradermally. Concomitant medication was not reported. On 10/26/2006, the pt gave Pneumococcal 23v polysaccharide vaccine was inadvertently administered because of human error. The pt reported that her arm was swollen. The pt sought unspecified medical attention and was told to put ice on the swollen area which persisted. The events were considered to be other important medical events (OMIC). Additional information has been requested.
p/vax pt exp red, sore, and swollen inj site; site no longer red but there is a small lump at the side;
cellulitis (arm got stiff between shoulder and elbow, arm was red and purple, warm to touch,skin was peeling at injection site); A spontaneous report was received from a consumer concerning a 78-year-old male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced arm stiffness between the shoulder and elbowthat progressed to the arm becoming red, purple, warm to touch, and the skin was peeling at the injection site.  After one week the patient went to urgent care and was diagnosed with cellulitis.  The patient's medical history was not provided. No relevant concomitant medication was reported.  On 12 Jan 2021, the patient received the first of their first planned doses of mRNA-1273 (lot number 012L20A) intramuscularly for prophylaxis of COVID-19 infection.  On 15 Jan 2021, the patient experienced arm stiffness between the shoulder and elbowthat progressed to the arm becoming red, purple, warm to touch, and the skin was peeling at the injection site.  After one week the patient went to urgent care and was diagnosed with cellulitis.   The patient was treated with an unspecified antibiotic, Benadryl, and Tylenol.  Action taken with the mRNA-1273 in response to the event was not reported, however, the patient's primary care physician advised the patient not to take the second dose of the vaccine.  The outcome of the event, cellulitis, was considered not resolved on an unkniwn date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event, a causal relationship cannot be excluded.
patient presented to minute clinic for evaluation post a covid booster injection. patient states he was vaccinated at this home town, he is in another state due to a competition. patient states that he got the vaccine on 12/3. on 12/4 he noticed he was extemely dizzy. on 12/5 that symptoms subsided however he noticed he had pain at injection site and swelling in his right axila region
inadvertent administration is reported in a pt who recvd .5cc flu vax lot# 01872P, exp 30JUN93; pt recvd expired flu vax 11OCT93; pt did not exp soreness or other apparent sx;
Dose number one September 21, 2021 - Sore arm for two days. Dose number two February 6, 2022 - Fever 101 degrees, shivering, body shaking when exposed to slightly colder temperature, muscle pain, tiredness, headache, stomach pain, nausea, dizziness,  sensitive skin, blurry vision. Unable to do regular activities.
Pt called Dr. last night (06/27/18) with vomiting but no abdominal pain or fever. She had the SHINGRIX vaccine #2 yesterday. The vomiting has stopped but she has diffuse muscle aches today. No fever.
10/14 slight soreness in arm that night 10/16 redness and swelling on underside of L upper arm
Disgusted with the salty metallic taste in her mouth; Lost some weight; Feels depressed; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic lymphocytic leukaemia.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed). At the time of the report, DYSGEUSIA (Disgusted with the salty metallic taste in her mouth), WEIGHT DECREASED (Lose some weight) and DEPRESSION (Feels depressed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter. The patient went to her dentist and doctor in regards to her reaction, but they are unsure of what caused it. Her sense of smell is fine and she had some blood work done (results are pending).
Flu vaccine was supposed to be given. MA did not verify vaccine, lot number, or patient prior to administration. No adverse effects were reported by parents. Parents were notified after the event and followed up 3 days after. Patient well and had no adverse side effects.
the "29 week pregnant patient was inadvertently administered a dose of VARIVAX; This spontaneous prospective pregnant report was received from a registered nurse referring to a pregnant female patient of unknown age. The patient had no pertinent medical history and drug reactions/ allergies. Concomitant medication was not reported.      On 27-JAN-2020, the patient who was at 29 weeks of pregnancy was inadvertently vaccinated with a dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot# S002736 with expiration date 28-JAN-2021, subcutaneous; dose was not reported) for negative titers for varicella(exposure during pregnancy).  The patient's last menstrual period (LMP) was on 08-JUL-2019 and estimated date of delivery (EDD) was on 13-APR-2020. The pregnancy outcome was pending. The outcome of the event was unknown.
I have not had an adverse reaction. I am reporting that my husband and I asked for a Covid vaccine at Pharmacy 10/10/23. We were told Pfizer was available and we agreed. Later when we went to another pharmacy for an influenza vaccine we were told the records showed we had received both a Covid vaccine and an influenza vaccine. We are sure we only received one vaccine. I do not know if I have filled in the names of the vaccines correctly above but the lot numbers are correct. Now we are not sure which vaccine we received. We want to be sure we are as protected as possible.
I have routine cov-19 weekly test, no positive history and no any physical discomfort prior to following event. 1/4/2021, received cov-19 test, sampling through nose, the immediately received vaccine after test sampling. (test result came out 2 days after and was negative). started to feel moderate pain in left arm and low fever (temperature 99.4 , test under tongue), lost appetite  for 10 days. feel better after 1/14/2021,  weekly routine test on 1/12/2021, received positive result in 1/14/2021.  no family member test positive, no contacted co-workers test positive at this period.  I ASSUME the tested cov-19 positive IS related to the Vaccine I received.
This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 15-SEP-2016, the patient was vaccinated with a dose of PROQUAD (dosing details not known) (lot # M011664, expiry date: 08-SEP-2017) that underwent temperature excursions prior to administration. The administered doses experienced a maximum temperature excursion of 24.1 degrees Fahrenheit for 17.75 hours. The excursions happened sometime during the time frame started on an unknown date in May 2016 and ended on 14-SEP-2016. No known adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Neck inflammation; This case was reported by a pharmacist via call center representative and described the occurrence of inflammation in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th December 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced inflammation. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the inflammation was unknown.   The reporter considered the inflammation to be unrelated to Shingrix.  Additional case details were reported as follows: The reporter stated that the patient experienced neck inflammation after vaccination. The patient steroid injection after the first dose of Shingrix because a neck inflammation. The patient was going to receive the second dose of Shingrix. The reporter consented to follow up.
Patient received her first COVID Vaccine on 6/4/2021 and on 6/5/2021, 6/6/2021, 6/7/2021, and 6/8/2021, she experienced chest pain and shortness of breath.  She experienced shortness of breath even when ascending the staircase in our home.  She felt chest pain and tightness in her chest for 4 days after receiving her vaccine.
Symptomatic; cough, runny nose, shortness of breath, sore throat, headache, and burning eyes.
This spontaneous report was received from a physician regarding an 11 year old female patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On 14-APR-2018, the patient was vaccinated with GARDASIL 9 (lot # M024261 with expiration date 30-JUL-2018) for prevention of cervical cancer, inadvertenly mixed with MENACTRA, lot # U5841AA with expiration date 08-MAR-2019 for an unknown indication (frequency and route were not provided). The patient received 0.5mL in "each deltoid" (wrong technique in product usage process). No treatment was given for the event. No adverse effects were reported.
shortness of breath for two days, came in to the er and found to have bilateral pulmonary embolus, heparin gtt and hospitalization
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 22-APR-2011, patient received improperly stored VARIVAX dose 1, from lot # 0552Z (dose and expiry date unknown). On 10-JUN-2011, the patient received second dose of VARIVAX from (lot #669223/1564Z expiry date: 11-NOV-2012) which was improperly stored. No adverse effects were reported. The reported stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
pt recv vax 15JUN95 & devel raised welts on 23JUN95;
Client stated that the evening after receiving her shot she had redness, swelling, and slight pain at site of injection.
Ear popped and am still unable to hear out of left ear. It will have ringing but not able to hear talking or tv out of it. This happened at week 24 of pregnancy
Per patient's self- report of event: "I had extreme pain and pressure in my head, which started around 2am and lasted until about 10am. The pain was so severe I was nauseous and dizzy. There was also heat radiating from the crown of my head. Others could feel it from about a foot away. I had difficulty breathing and shortness of breath which lasted from about 2am-10am as well and this was also accompanied with chills. My chills lasted for about 3 days and after the brain pressure and trouble breathing subsided. I had a fever of about 100 degrees F, a headache and extreme fatigue which also lasted for about 3 days.
At first mild Shortness of breath increase to an alarming amount.  Then slight fever 101, then chills and shakes.  The next morning all symptoms were gone.
left foot started to feel funny, then the leg  started to swell. difficult to walk pain and unsteady
redness/swelling @ inject site 70x130mm; tired & lightheaded; minimal nausea w/o appetite;
This case was reported by a pharmacist via call center representative and described the occurrence of local swelling in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced local swelling, injection site pain and inflammation. On an unknown date, the outcome of the local swelling, injection site pain and inflammation were recovered/resolved.  It was unknown if the reporter considered the local swelling, injection site pain and inflammation to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. But, it could be 62 or 63 years. The healthcare professional reported that, the patient had come in for her 2nd dose of SHINGRIX and reported, local swelling, inflammation, and pain in response to the 1st dose that had since resolved. The healthcare professional could not provide batch number and expiry date as the dose was given at a different practice site.
After vaccines client fainted unresponsive, color pale, incontinent of urine, assisted to floor with feet elevated, applied cold compress to neck & head - P-78 - R-22 - revived with sternal rub - seen by Dr.
Rash/Hives occurring two days after vaccination; Rash/Hives occurring two days after vaccination; This is a spontaneous report from a contactable other hcp. A 35-years-old male patient received second dose of bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot number was not reported) intramuscular, administered in arm right on 19Feb2021as second dose, single for COVID-19 immunization. It was reported that the patient had no allergies. The patient medical history and concomitant was not reported. The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID was unknown. Post vaccination patient did not test for COVID. Patient previously took first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot Number was not reported) via an unspecified route of administration, administered on unknown date as first dose, single for COVID-19 immunization. It was reported that on 21Feb2021 the patient experienced Rash/Hives occurring two days after vaccination. Treated with 5 days of prednisone and hydroxyzine without relief. Therapeutic measures were taken as a result of rash/hives occurring two days after vaccination. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Monday night, I called into work for the next day. I had a fever, sore throat, cough, congestion, body aches. Tuesday morning, I made an appt to get swabbed because my children were sick. I took Tylenol and Ibuprofen. No other treatment.  Had fever, 101 -102 degrees, for November 2-5th. Once the fever broke, the body aches went away. Still have a residual cough - it's spread into my sinuses. Can't cough anything up. I am working today but from home. Flu shot had it after COVID 19 shot about two weeks ago.
Light headedness, pressure on chest, and headache after injection. Light headedness and pressure on chest went away but headache has not gone away since vaccination. Abdominal pain started the day after vaccination and lasted until nine days after.
Patient with 2 COVID vaccinations, last dose 03/09/21, who presented to the hospital with COVID complications.  Provider discharge summary below:  "patient presented with n/v/abdominal pain found to be covid positive and have pneumonia/gastroenteritis. GI symptoms quickly resolved. She was mildly hypoxic which also resolved. Given remdesivir and decadron while hospitalized. Once she was off oxygen she was discharged back to her AFC."
Information has been received from an advanced registered nurse practitioner concerning an 18 year old female patient who on 23-DEC-2010 was vaccinated with a dose of GARDASIL, dose and route unspecified (Lot # 661046/0546X Exp date. 01-DEC-2010). The nurse stated that the patient "passed out" approximately two minutes after receiving the dose of GARDASIL. The nurse also stated that the patient spontaneously regained consciousness, and that when she checked on the patient later the same evening, she reported no additional adverse experiences. The patient sought unspecified medical attention. Additional information has been requested.
Patient complaints as COVID vaccination as following; numbness, tingling, and cold sensations on left 4th finger. After 15-20 minutes later, the patient had full sensation, color, ROM, and temperature on all 4 fingers. No further medical intervention needed.